
En desarrollo
Política·4/6/2026Resumen IA
Europe's Health Ambition: Prioritizing Innovation vs. Patient Access Delays
European patients face increasing delays in accessing new medicines, with average wait times reaching 597 days. Despite strong scientific innovation, fragmented national systems hinder timely access post-approval. An 'Access from Day 1' approach is proposed to streamline pathways, ensuring innovation reaches patients faster and more equitably.
P
Politico EU4 min de lectura